The Purpose of the Study is to Evaluate the Effect of Ruxolitinib Cream on Itch in Participants With Atopic Dermatitis
Clinical trial NCT04839380 · COMPLETED
Trial details
- NCT number
- NCT04839380
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-12
- Primary completion
- 2022-11-18
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.